NCT04654403 2021-08-23
Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer
The First Affiliated Hospital of Zhengzhou University
Phase NA Unknown
The First Affiliated Hospital of Zhengzhou University
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital